Search Results - "Thürmann, Petra A"

The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries by Renom-Guiteras, Anna, Meyer, Gabriele, Thürmann, Petra A.

“…Purpose The aim of the study was to develop a European list of potentially inappropriate medications (PIM) for older people, which can be used for the analysis…”
Get full text

Potentially Inadequate Medications in the Elderly: PRISCUS 2.0 by Mann, Nina-Kristin, Mathes, Tim, Sönnichsen, Andreas, Pieper, Dawid, Klager, Elisabeth, Moussa, Mahmoud, Thürmann, Petra A

“…BACKGROUNDThe term potentially inadequate medication (PIM) is used to describe substances that may be unsuitable for use inthe elderly and should be avoided…”
Get full text

Potentially inappropriate medication among people with dementia in eight European countries by Renom-Guiteras, Anna, Thürmann, Petra A, Miralles, Ramón, Klaaßen-Mielke, Renate, Thiem, Ulrich, Stephan, Astrid, Bleijlevens, Michel H C, Jolley, David, Leino-Kilpi, Helena, Rahm Hallberg, Ingalill, Saks, Kai, Soto-Martin, Maria, Zabalegui, Adelaida, Meyer, Gabriele

“…Abstract Objectives to evaluate the frequency of potentially inappropriate medication (PIM) prescription among older people with dementia (PwD) from eight…”
Get full text

Impact of timing and combination of different BNT162b2 and ChAdOx1-S COVID-19 basic and booster vaccinations on humoral immunogenicity and reactogenicity in adults by Dedroogh, Simon, Schmiedl, Sven, Thürmann, Petra A., Graf, Katharina, Appelbaum, Sebastian, Koß, Reinhard, Theis, Christian, Zia, Zewarudin, Tebbenjohanns, Jürgen, Thal, Serge C., Dedroogh, Michael

“…In this single-center observational study with 1,206 participants, we prospectively evaluated SARS-CoV-2-antibodies (anti-S RBD) and vaccine-related adverse…”
Get full text

Comparing Predictions of a PBPK Model for Cyclosporine With Drug Levels From Therapeutic Drug Monitoring by Zapke, Sonja E., Willmann, Stefan, Grebe, Scott-Oliver, Menke, Kristin, Thürmann, Petra A., Schmiedl, Sven

“…This study compared simulations of a physiologically based pharmacokinetic (PBPK) model implemented for cyclosporine with drug levels from therapeutic drug…”
Get full text

Influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trial by Nachtigall, Angela, Heppner, Hans J, Thürmann, Petra A

“…Demographic shift leads to an increasing number of geriatric patients suffering from multimorbidity and resulting polypharmacy. Polypharmacy is shown to be…”
Get full text

Development and Pilot-Testing of Key Questions to Identify Patients' Difficulties in Medication Administration by Wurmbach, Viktoria S, Schmidt, Steffen J, Lampert, Anette, Bernard, Simone, Faller, Christine K, Thürmann, Petra A, Haefeli, Walter E, Seidling, Hanna M

“…The development and testing of key questions suitable to identify patients' difficulties with medication administration. We used a consecutive five-step…”
Get full text

Development of an algorithm to detect and reduce complexity of drug treatment and its technical realisation by Wurmbach, Viktoria S, Schmidt, Steffen J, Lampert, Anette, Frick, Eduard, Metzner, Michael, Bernard, Simone, Thürmann, Petra A, Wilm, Stefan, Mortsiefer, Achim, Altiner, Attila, Sparenberg, Lisa, Szecsenyi, Joachim, Peters-Klimm, Frank, Kaufmann-Kolle, Petra, Haefeli, Walter E, Seidling, Hanna M

“…The increasing complexity of current drug therapies jeopardizes patient adherence. While individual needs to simplify a medication regimen vary from patient to…”
Get full text

Development of a deprescribing manual for frail older people for use in the COFRAIL study and in primary care by Mann, Nina-Kristin, Schmiedl, Sven, Mortsiefer, Achim, Bencheva, Veronika, Löscher, Susanne, Ritzke, Manuela, Drewelow, Eva, Feldmeier, Gregor, Santos, Sara, Wilm, Stefan, Thürmann, Petra A.

“…Introduction: Many older adults are affected by multimorbidity and subsequent polypharmacy which is associated with adverse outcomes. This is especially…”
Get full text

Reduction of potentially inappropriate medication in the elderly: design of a cluster-randomised controlled trial in German primary care practices (RIME) by Thiem, Ulrich, Wilm, Stefan, Greiner, Wolfgang, Rudolf, Henrik, Trampisch, Hans–Joachim, Müller, Christiane, Theile, Gudrun, Thürmann, Petra A.

“…Background: Potentially inappropriate medication (PIM) is considered to have potentially more harmful than beneficial health effects in elderly patients. A…”
Get full text

HIOPP-6 – a pilot study on the evaluation of an electronic tool to assess and reduce the complexity of drug treatment considering patients’ views by Wurmbach, Viktoria S, Schmidt, Steffen J, Lampert, Anette, Bernard, Simone, Meid, Andreas D, Frick, Eduard, Metzner, Michael, Wilm, Stefan, Mortsiefer, Achim, Bücker, Bettina, Altiner, Attila, Sparenberg, Lisa, Szecsenyi, Joachim, Peters-Klimm, Frank, Kaufmann-Kolle, Petra, Thürmann, Petra A, Seidling, Hanna M, Haefeli, Walter E

“…Abstract Background A complex drug treatment might pose a barrier to safe and reliable drug administration for patients. Therefore, a novel tool automatically…”
Get full text

Pharmacodynamics and pharmacokinetics in older adults by Thürmann, Petra A.

“…With the growing of the aging population, increased and new methods of anesthesia and surgery allow for surgery and other interventions in older…”
Get full text

Is less more? Patients' preferences for drug information leaflets by Schwappach, David L.B., Mülders, Verena, Simic, Dusan, Wilm, Stefan, Thürmann, Petra A.

“…ABSTRACT Purpose Present package information leaflets do not fulfil the needs of many patients. The objective of this study was to investigate patients'…”
Get full text

Operacionalização para Portugal da Lista EU(7)-PIM para Identificação de Medicamentos Potencialmente Inapropriados nos Idosos by Rodrigues, Daniela A., Herdeiro, Maria T., Thürmann, Petra A., Figueiras, Adolfo, Coutinho, Paula, Roque, Fátima

“…Introdução: Em 2015 foi publicada a lista EU(7)-PIM, que identifica medicamentos potencialmente inapropriados na população idosa e resultou de um consenso de…”
Get full text

Plasma kinetics of lutein, zeaxanthin, and 3'-dehydro-lutein after multiple oral doses of a lutein supplement by Thurmann, P.A, Schalch, W, Aebischer, J.C, Tenter, U, Cohn, W

“…Background: Adequate intake of lutein is postulated to reduce the risk of age-related macular degeneration, but kinetic information for developing a dosing…”
Get full text

Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension by THÜRMANN, P. A, KENEDI, P, SCHMIDT, A, HARDER, S, RIETBROCK, N

“…Left ventricular hypertrophy (LVH) represents an independent risk factor in patients with essential hypertension. Because reversal of LVH may be associated…”
Get full text

Plasma kinetics of zeaxanthin and 3'-dehydro-lutein after multiple oral doses of synthetic zeaxanthin by Hartmann, D, Thurmann, P.A, Spitzer, V, Schalch, W, Manner, B, Cohn, W

“…Background: Zeaxanthin is hypothesized to reduce the risk of age-related macular degeneration; however, kinetic information is limited. Objectives: The…”
Get full text

Potentially inappropriate medications in the elderly: the PRISCUS list by Holt, Stefanie, Schmiedl, Sven, Thürmann, Petra A

“…Certain drugs are classified as potentially inappropriate medications (PIM) for the elderly because they carry an increased risk of adverse drug events in this…”
Get full text

Trends and patterns in EU(7)-PIM prescribing to elderly patients in Germany by Selke Krulichová, Iva, Selke, Gisbert W., Thürmann, Petra A.

“…Purpose The aim of this study was to explore patterns and long-term development in prescribing potentially inappropriate medication (PIM) according to the…”
Get full text

Detecting adverse drug reactions on paediatric wards : Intensified surveillance versus computerised screening of laboratory values by HAFFNER, Steffen, VON LANE, Nicoletta, WIRTH, Stefan, THÜRMAM, Petra A

“…Adverse drug reactions (ADRs) contribute significantly to patient morbidity and mortality, as well as to costs for healthcare systems. Our aim was to evaluate…”
Get full text